15-39991049-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001013703.4(EIF2AK4):c.2631+672T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.53 in 152,444 control chromosomes in the GnomAD database, including 22,900 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.53 ( 22819 hom., cov: 33)
Exomes 𝑓: 0.65 ( 81 hom. )
Consequence
EIF2AK4
NM_001013703.4 intron
NM_001013703.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.401
Publications
5 publications found
Genes affected
EIF2AK4 (HGNC:19687): (eukaryotic translation initiation factor 2 alpha kinase 4) This gene encodes a member of a family of kinases that phosphorylate the alpha subunit of eukaryotic translation initiation factor-2 (EIF2), resulting in the downregulaton of protein synthesis. The encoded protein responds to amino acid deprivation by binding uncharged transfer RNAs. It may also be activated by glucose deprivation and viral infection. Mutations in this gene have been found in individuals suffering from autosomal recessive pulmonary venoocclusive-disease-2. [provided by RefSeq, Mar 2014]
EIF2AK4 Gene-Disease associations (from GenCC):
- pulmonary veno-occlusive disease and/or pulmonary capillary haemangiomatosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- pulmonary venoocclusive disease 2Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- heritable pulmonary arterial hypertensionInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pulmonary venoocclusive diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.639 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| EIF2AK4 | NM_001013703.4 | c.2631+672T>C | intron_variant | Intron 16 of 38 | ENST00000263791.10 | NP_001013725.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EIF2AK4 | ENST00000263791.10 | c.2631+672T>C | intron_variant | Intron 16 of 38 | 2 | NM_001013703.4 | ENSP00000263791.5 | |||
| EIF2AK4 | ENST00000560855.5 | c.1962+672T>C | intron_variant | Intron 11 of 33 | 5 | ENSP00000453575.1 | ||||
| EIF2AK4 | ENST00000558629.5 | n.-117T>C | upstream_gene_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.530 AC: 80517AN: 151956Hom.: 22815 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
80517
AN:
151956
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.649 AC: 240AN: 370Hom.: 81 AF XY: 0.643 AC XY: 148AN XY: 230 show subpopulations
GnomAD4 exome
AF:
AC:
240
AN:
370
Hom.:
AF XY:
AC XY:
148
AN XY:
230
show subpopulations
African (AFR)
AF:
AC:
4
AN:
8
American (AMR)
AF:
AC:
3
AN:
4
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
2
East Asian (EAS)
AF:
AC:
1
AN:
2
South Asian (SAS)
AF:
AC:
2
AN:
2
European-Finnish (FIN)
AF:
AC:
58
AN:
94
Middle Eastern (MID)
AF:
AC:
3
AN:
6
European-Non Finnish (NFE)
AF:
AC:
158
AN:
234
Other (OTH)
AF:
AC:
10
AN:
18
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.530 AC: 80560AN: 152074Hom.: 22819 Cov.: 33 AF XY: 0.529 AC XY: 39314AN XY: 74340 show subpopulations
GnomAD4 genome
AF:
AC:
80560
AN:
152074
Hom.:
Cov.:
33
AF XY:
AC XY:
39314
AN XY:
74340
show subpopulations
African (AFR)
AF:
AC:
13504
AN:
41464
American (AMR)
AF:
AC:
7582
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
2378
AN:
3472
East Asian (EAS)
AF:
AC:
2678
AN:
5158
South Asian (SAS)
AF:
AC:
2398
AN:
4824
European-Finnish (FIN)
AF:
AC:
6305
AN:
10578
Middle Eastern (MID)
AF:
AC:
170
AN:
294
European-Non Finnish (NFE)
AF:
AC:
43769
AN:
67970
Other (OTH)
AF:
AC:
1188
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1871
3742
5614
7485
9356
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
694
1388
2082
2776
3470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1643
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.